The impact of hepatic diseases is substantial, demanding groundbreaking therapeutic strategies. Cellular therapies represent a particularly exciting avenue, offering the chance to repair damaged parenchymal tissue and alleviate patient outcomes. Currently, research focuses on several approaches, including the introduction of adult cellular entities